Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Recombinant Human Leptin Therapy Effects on Insulin Action [NA]
A completed clinical trial evaluated whether recombinant human leptin improves insulin action in individuals with type 2 diabetes; results w…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Preferred Treatment of Type 1.5 Diabetes [NA]
A completed University of Washington clinical trial evaluating preferred treatment for Type 2 diabetes mellitus. Results were posted in 2011…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Peanuts Second Meal Glycemic Response [NA]
A completed clinical trial studying the glycemic response after a second peanut-containing meal in individuals with Type 2 Diabetes Mellitus…
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: LANN-study: Lantus, Amaryl, Novorapid, Novomix Study [Phase 3]
Phase 3 clinical trial update for a type 2 diabetes study using Lantus, Amaryl, NovoRapid, and Novomix; the trial has completed.
-
CLINICAL_TRIALS research · 2011-08-09Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes [Phase 1, Phase 2]
A phase 1/2 clinical trial from Shandong University is evaluating the safety and potential efficacy of Umbilical Cord/Placenta-Derived Mesen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: A Pilot Trial of the EndoBarrier™ Flow Restrictor for Glycemic Improvement in Type 2 Diabetics
A pilot clinical trial evaluating the EndoBarrier Flow Restrictor device for glycemic improvement in Type 2 diabetes has completed.
-
FDA approval · 2011-08-05FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) from AstraZeneca Pharmaceuticals LP. The approval concerns a supplemental sub…
-
CLINICAL_TRIALS research · 2011-08-05Clinical Trial Update: Glycemic and Satiety Response to Fiber and Glycemic Index of Meals in Diabetes [NA]
A clinical trial update evaluating how fiber content and the glycemic index of meals influence glycemic response and satiety in people with …
-
CLINICAL_TRIALS research · 2011-08-05Clinical Trial Update: Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial update for Tele-Diab electronic diary in patients with Type 2 diabetes mellitus; the current trial status is unknow…
-
FDA approval · 2011-08-04FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Pioglitazone and Glimepiride from Prasco Laboratories.
-
FDA label_change · 2011-08-04FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA page notes a supplemental application for ACTOS (pioglitazone) by Takeda Pharmaceuticals America, Inc., indicating a change to the e…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design [Phase 3]
A Phase 3 factorial trial evaluating the safety and efficacy of linagliptin in combination with metformin in adults with Type 2 diabetes; re…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating whether combining enalapril and losartan affects proteinuria and inflammatory biomarkers in macroalbuminur…
-
FDA approval · 2011-08-04FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Actoplus Met (pioglitazone and metformin hydrochloride) from Takeda Pharmaceuticals America, Inc…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes [NA]
A completed study evaluating how aerobic and aerobic-resistance exercise affects glucose profiles measured by continuous glucose monitoring …
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Japanese P III vs Voglibose and Placebo [Phase 3]
Phase 3 trial in Japan comparing Boehringer Ingelheim's experimental compound to voglibose and placebo in type 2 diabetes; results were post…
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled 18-week study evaluating linagliptin (BI 1356) added to a sulfonylurea in adults with…
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control [Phase 4]
This Phase 4 clinical trial examined the effects of blood glucose self-monitoring and HbA1c on glucose control in individuals with Type 2 di…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients [Phase 4]
Phase 4 clinical trial evaluating the glycemic effects of nebivolol compared with metoprolol and hydrochlorothiazide in patients with hypert…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Probiotics as a Novel Approach to Modulate Gut Hormone Secretion and Risk Factors of Type 2 Diabetes and Complications [Phase 1, Phase 2]
This update describes Phase 1/Phase 2 clinical trials evaluating probiotic strategies to modulate gut hormone secretion. The studies target …
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Internet Diabetes Self-Management [Phase 2]
The clinical trial update reports the completion of a Phase 2 study evaluating an Internet-based diabetes self-management program for Type 2…
-
FDA approval · 2011-07-27FDA Approved: ACARBOSE — Original Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's generic acarbose (ACARBOSE) under an Original Application (ANDA). This approval enables ma…
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Lifestyle Intervention in Patients With New Onset Type 2 Diabetes. [NA]
This update notes the completion of a clinical trial evaluating lifestyle intervention in patients with newly diagnosed Type 2 diabetes mell…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing insulin detemir, insulin aspart, and biphasic insulin aspart 30 added to oral antidiabetic therapy in adults with …
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients
This entry reports the completion of a clinical trial evaluating whether lipid-lowering therapy is necessary for patients with type 2 diabet…